Ardelyx reported $-27643000 in EBIT for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2331M 232M
Acceleron Pharma XLRN:US $ -63603000 6.01M
Amgen AMGN:US $ 2129M 121M
Astrazeneca AZN:US 1.03B 425M
Biocept BIOC:US $ 2.66M 697.81K
Chimerix CMRX:US -14563000 2.81M
Corcept Therapeutics CORT:US $ 19.64M 10.87M
Opko Health OPK:US $ 38.44M 10.92M
United Therapeutics UTHR:US $ -41700000 107M
Xoma XOMA:US $ -6427000 30.3M